Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Tesla (TSLA) PT Raised to $400 at Jefferies
• HSBC Upgrades Capital One Financial (COF) to Buy
• Citi Opens 90-Day Upside Catalyst Watch on Illinois Tool Works (ITW)